MDCE News & Milestones
Revenue Pathways
Regulation A Offering
Ticker / Name Change
Medical Care Technologies Inc. (through its subsidiaries, Real Game Used and Infinite Auctions) generates revenue from multiple high-value sources, including auction commissions, authentication services, private sales of premium memorabilia, and exceptionally profitable discoveries of photo-matched items identified using its proprietary AI technology.
Ticker / Name Change
Regulation A Offering
Ticker / Name Change
Our corporate name change application has been formally submitted to FINRA, and we anticipate receiving notification regarding its approval status in the fourth quarter of 2025. As part of this process, we have applied for the new ticker symbols HOF, SLAM, and DUNK. We believe this rebranding effort will bring added excitement and greater clarity to our identity.
Patent Pending AI
Regulation A Offering
Regulation A Offering
Our patent application for our proprietary AI software has been fully completed and submitted for approval. This groundbreaking technology is a first-of-its-kind in the memorabilia industry—a true trailblazer in how historic items are identified, analyzed, and authenticated. We have already begun monetizing this innovation through successful, high-value discoveries and sales.
Regulation A Offering
Regulation A Offering
Regulation A Offering
The company has successfully raised capital through its ongoing Regulation A offering, with proceeds strategically allocated toward marketing initiatives, investor relations efforts, and the acquisition of high-value inventory intended to drive future revenue. The Reg A offering is scheduled to conclude in the fourth quarter of 2025. Howe
The company has successfully raised capital through its ongoing Regulation A offering, with proceeds strategically allocated toward marketing initiatives, investor relations efforts, and the acquisition of high-value inventory intended to drive future revenue. The Reg A offering is scheduled to conclude in the fourth quarter of 2025. However, if the share price does not show a meaningful rebound, the company may evaluate the option of pausing or canceling the offering to protect shareholder value